Jun 23, 2026 07:00AM
Jun 23, 2026 07:00AM
Jun 8, 2026 09:00AM
May 15, 2026 12:12PM
May 15, 2026 12:11PM
May 7, 2026 07:00AM
May 5, 2026 07:01AM Amylyx launches expanded access program for post-bariatric hypoglycemia drug
May 5, 2026 07:00AM
Mar 25, 2026 06:57AM
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Mar 3, 2026 07:00AM
Dec 19, 2025 09:06AM
Dec 5, 2025 09:00AM Amylyx reports early safety data for ALS drug AMX0114
Dec 5, 2025 09:00AM
Nov 6, 2025 07:00AM
Oct 20, 2025 07:49AM
Oct 8, 2025 08:44AM
Aug 27, 2025 07:05AM
Aug 27, 2025 07:00AM
Aug 7, 2025 07:00AM Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results
Jul 14, 2025 03:41PM
Jul 13, 2025 05:00PM
Jul 8, 2025 07:00AM
Jun 17, 2025 05:17AM
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM
May 12, 2025 07:01AM Amylyx Pharmaceuticals (AMLX) Announces Positive Long-Term Results from Phase 2 HELIOS Trial of AMX0035
May 12, 2025 07:00AM
May 8, 2025 07:00AM
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM
Mar 4, 2025 06:00AM
Jan 21, 2025 09:00AM
Jan 21, 2025 09:00AM Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Jan 6, 2025 09:00AM
Dec 4, 2024 07:32AM
Dec 4, 2024 07:30AM
Nov 21, 2024 05:09AM
Nov 7, 2024 07:00AM
Oct 18, 2024 06:44AM
Oct 18, 2024 05:46AM Leerink Partners Reiterates Market Perform Rating on Amylyx Pharmaceuticals inc. (AMLX)
Oct 17, 2024 09:01AM
Oct 17, 2024 09:00AM
Aug 8, 2024 07:00AM
Aug 2, 2024 09:00AM
Jul 11, 2024 10:30AM
Jul 10, 2024 07:00AM
Jul 10, 2024 07:00AM Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation
May 9, 2024 07:00AM

323,981 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All